See more : Kufu Company Inc. (4376.T) Income Statement Analysis – Financial Results
Complete financial analysis of MediPharm Labs Corp. (LABS.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MediPharm Labs Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- BExcellent Group Holdings Limited (1775.HK) Income Statement Analysis – Financial Results
- Taiwan Kong King Co.,Ltd (3093.TWO) Income Statement Analysis – Financial Results
- Dongfeng Motor Group Company Limited (DNFGY) Income Statement Analysis – Financial Results
- Metals Acquisition Corp (MTAL-WT) Income Statement Analysis – Financial Results
- Uranium Royalty Corp. (URC.TO) Income Statement Analysis – Financial Results
MediPharm Labs Corp. (LABS.TO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.medipharmlabs.com
About MediPharm Labs Corp.
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.06M | 22.12M | 21.71M | 36.01M | 129.25M | 10.20M | 0.00 | 0.00 |
| Cost of Revenue | 27.21M | 24.03M | 36.96M | 79.99M | 86.34M | 6.23M | 0.00 | 0.00 |
| Gross Profit | 5.85M | -1.91M | -15.25M | -43.98M | 42.91M | 3.97M | 0.00 | 0.00 |
| Gross Profit Ratio | 17.71% | -8.65% | -70.22% | -122.12% | 33.20% | 38.90% | 0.00% | 0.00% |
| Research & Development | 209.00K | 1.00M | 1.36M | 2.23M | 867.00K | 261.00K | 0.00 | 0.00 |
| General & Administrative | 21.64M | 18.45M | 18.40M | 24.59M | 30.86M | 5.54M | 746.00K | 82.14K |
| Selling & Marketing | 3.16M | 6.30M | 4.63M | 4.37M | 3.33M | 1.27M | 201.00K | 9.66K |
| SG&A | 24.80M | 24.76M | 23.03M | 28.95M | 34.19M | 6.82M | 947.00K | 133.94K |
| Other Expenses | -898.00K | 1.12M | 3.38M | -4.13M | 920.00K | 4.92M | 0.00 | 0.00 |
| Operating Expenses | 24.11M | 26.88M | 27.76M | 27.05M | 35.98M | 11.99M | 988.00K | 133.94K |
| Cost & Expenses | 51.31M | 50.91M | 64.72M | 107.04M | 122.31M | 18.23M | 988.00K | 133.94K |
| Interest Income | 840.00K | 479.00K | 225.00K | 273.00K | 486.00K | 64.00K | 0.00 | 0.00 |
| Interest Expense | 365.00K | 31.00K | 10.51M | 7.88M | 672.00K | 364.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 2.52M | 2.87M | 5.63M | 10.81M | 2.53M | 982.00K | 948.00K | 133.94K |
| EBITDA | -10.48M | -27.09M | -38.55M | -53.40M | 9.98M | -7.00M | -42.00K | 0.00 |
| EBITDA Ratio | -31.69% | -115.02% | -171.12% | -166.47% | 7.70% | -69.57% | 0.00% | 0.00% |
| Operating Income | -18.25M | -29.53M | -48.92M | -72.58M | 6.94M | -8.03M | -948.00K | -133.94K |
| Operating Income Ratio | -55.21% | -133.53% | -225.31% | -201.53% | 5.37% | -78.71% | 0.00% | 0.00% |
| Total Other Income/Expenses | 4.89M | -456.00K | -5.77M | 476.00K | -186.00K | -414.00K | -47.00K | 0.00 |
| Income Before Tax | -13.36M | -29.99M | -54.69M | -72.10M | 6.75M | -8.47M | -995.00K | -133.94K |
| Income Before Tax Ratio | -40.41% | -135.59% | -251.89% | -200.21% | 5.22% | -83.02% | 0.00% | 0.00% |
| Income Tax Expense | -276.00K | -6.00K | 113.00K | -4.99M | 5.62M | -55.00K | -47.00K | 0.00 |
| Net Income | -13.08M | -29.98M | -54.80M | -67.11M | 1.13M | -8.41M | -990.00K | -133.94K |
| Net Income Ratio | -39.57% | -135.57% | -252.41% | -186.35% | 0.88% | -82.48% | 0.00% | 0.00% |
| EPS | -0.04 | -0.11 | -0.22 | -0.48 | 0.01 | -0.12 | -0.20 | -0.07 |
| EPS Diluted | -0.04 | -0.11 | -0.22 | -0.48 | 0.01 | -0.12 | -0.20 | -0.07 |
| Weighted Avg Shares Out | 363.32M | 276.86M | 249.91M | 138.55M | 120.00M | 69.88M | 5.00M | 2.00M |
| Weighted Avg Shares Out (Dil) | 363.32M | 276.86M | 249.91M | 138.55M | 134.63M | 72.59M | 5.00M | 2.00M |
Source: https://incomestatements.info
Category: Stock Reports